Brief: Nanexa Signs Contract With Leading International Diabetes CRO For Phase I Study With NEX-22

Nanexa AB

01/06/2023 09:20

June 1 (Reuters) - Nanexa AB  NANEXA.ST :
    * NANEXA SIGNS CONTRACT WITH LEADING INTERNATIONAL DIABETES
CRO
FOR PHASE I STUDY WITH NEX-22
    * PHASE I STUDY OF NEX-22 EXPECTED TO BE READY TO START
AROUND END
OF 2023

Source text for Eikon:  ID:nMFNc3lb31 
Further company coverage:  NANEXA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))